Navigation Links
Ferring Pharmaceuticals Announces Immediate Availability of Degarelix for the Treatment of Advanced Prostate Cancer
Date:3/4/2009

p>

About Degarelix

Degarelix is an injectable gonadotropin-releasing hormone (GnRH) receptor antagonist approved by the U.S. Food and Drug Administration (FDA) for the treatment of hormone sensitive advanced prostate cancer. As a receptor antagonist, degarelix reversibly binds to the GnRH receptors in the pituitary gland, immediately suppressing the secretion of the luteinizing hormone (LH), follicle-stimulating hormone (FSH), and subsequently, testosterone levels.(4) Degarelix also reduces levels of prostate-specific antigen (PSA). Unlike LHRH agonists, such as leuprolide, an established treatment for prostate cancer, degarelix does not induce an initial testosterone surge. Degarelix is administered monthly by subcutaneous injection. The starting dose is 240 mg, followed by monthly maintenance doses of 80 mg. Degarelix is available for order through traditional and specialty pharmacy distributors. The average monthly cost of one year of degarelix treatment is comparable to other hormone treatments for prostate cancer.

About Prostate Cancer

Prostate cancer is the most common cancer, excluding skin cancers, and the second leading cause of cancer death in American men. About one man in six will be diagnosed with prostate cancer during his lifetime, and one in 35 will die of this disease.(5) Prostate cancer develops from cells in the prostate gland that begin to grow out of control. In most cases, prostate cancer grows slowly and can remain undetected throughout a man's life, although it can grow and spread quickly.(6) The four types of standard treatment are: watchful waiting, surgery, radiation therapy, and hormone therapy, also called androgen deprivation therapy (ADT).

About Ferring Pharmaceuticals Inc.

Ferring Pharmaceuticals Inc. is a subsidiary of Ferring Pharmaceuticals, a privately owned, international pharmaceutical company. Ferring Pharmaceuticals offer
'/>"/>

SOURCE Ferring Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine news :

1. Ferring Pharmaceuticals Promotes William Garbarini to Vice President of New Orthopaedics and Urology Business Unit
2. Dr. Jan Linhart Now Offerring Unique Laser Teeth Whitening System
3. Ferring Pharmaceuticals EUFLEXXA(R) to Serve as a Sponsor for the Babolat World Tennis Classic
4. Increase in Diagnostic Imaging Fueled by Self-Referring Doctors
5. Ferring Pharmaceuticals EUFLEXXA(TM) to Serve as Sponsor for Sprint Force America Masters Track Club
6. Ferring Announces $10,000 Grand Prize Winner of 2007 My Little Miracle Essay Contest
7. Frost & Sullivan Lauds OVATION Pharmaceuticals for Its Business Model and Ability to Sustain Growth
8. NovaBay Pharmaceuticals Announces New Preclinical Data to be Presented at the American Academy of Dermatology (AAD) 67th Annual Meeting
9. Levels of Trace Pharmaceuticals in Drinking Water Too Low to Impact Human Health According to Water Research Foundation Study
10. AUDIO from Medialink and Ortho-McNeil-Janssen Pharmaceuticals: Risks of Overusing Antibiotics
11. Onyx Pharmaceuticals to Present at the Barclays Capital Global Healthcare Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...,, LOSANGELES,Nov.25/PRNewswire-USNewswire/-...lectionstodetermineexecutiveleadershipfor2010. ,...rswithspecialtiesinpublicpolicy,law,finance,govern...urship.TheBoardalsocomesfromawiderangeofpersonalba...dwomen,somelivingwithHIVthemselves,andrepresenting...
(Date:11/25/2009)..., A fortuitous discovery that grew out of a col...ould potentially offer hope to the nearly 10 milli...isease. , Also known as hardening of the art...ommon circulatory problem in which narrowed arteri...s considered a red flag for vascular disease, hear...
(Date:11/25/2009)... Fatigue, forgetfulness could lead mothers to over...DAY, Nov. 25 (HealthDay News) -- A mother,s depres...rs have found. , Their six-month study of 262 b...n whose mothers had more depressive symptoms had m...thers with fewer depressive symptoms had less freq...
(Date:11/25/2009)...,, LittleImprovementShownforthe4thStraight...re/-- Today,LungCancerAlliance-Georgia(LCA-GA)iss...isanassessmentofprogressbeingmadeagainstthislethal...ancerAlliance(LCA),theonlynationalorganizationdedi...lelivingwithoratriskforlungcancer. ,, (Logo: ht...
(Date:11/25/2009)... Study found puffs of air on flesh that mimicked p... , WEDNESDAY, Nov. 25 (HealthDay News) -- Peo...with their skin, new research shows. , In fact,...types of speech actually helped people decipher so...We have never been able to show whether we could u...
Breaking Medicine News(10 mins):Health News:Black AIDS Institute Announces 2010 Board Election Results 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 4Health News:Mom's Depression May Worsen Child's Asthma 2Health News:Lung Cancer Alliance-Georgia Issues 4th Annual State-Specific Report Card on Lung Cancer 2Health News:Your Skin Can Help Your Ears Listen 2Health News:Your Skin Can Help Your Ears Listen 3
...m, AL -- Researchers have identified the receptor ...after trauma and hemorrhage//. The related report ...endent protein kinase A pathway is critical in non...is accompanied by a commentary. Research has sh...
...study finds that stents do not prevent heart attac...ts to minimize chest pains and to prevent heart at...lly into blocked arteries to keep them open. ...ting heart attacks than that is possible by drug t...
...rs have found that a cellular receptor involved in... and regeneration immediately following liver inju...arly intervention or therapy in liver disease such...terina Akassoglou, Ph.D. assistant professor in UC...
...has sought the help of a premier Jaipur-based inst... A high-level delegation headed by the Malaysia...f Ayurveda (NIA) in Jaipur to check out the academ... institute for developing ayurveda in their countr...
...ic researchers report that freezing kidney tumors ...r patients who are not good candidates// for surge...s in more than 90 percent of selected patients are...ure. For some patients, surgery is not an option, ...
...dy suggests that people whose diets contain dramat...cid than another may be at greater risk// for both...ases. The report, published online this week...an diet contains 20 times more omega-6 than omega-...
Other Medicine News:Health News:Estrogen Protects Liver After Traumatic Injury 2Health News:Stents Do Little to Prevent Heart Attacks 2Health News:Hepatic Stellate Cells Found Capable of Tissue Repair 2Health News:Cryoablation: A New Treatment Option for Some Kidney Tumor Patients 2Health News:Cryoablation: A New Treatment Option for Some Kidney Tumor Patients 3Health News:Omega-3 Fatty Acids Affect Risk of Depression, Inflammation 2Health News:Omega-3 Fatty Acids Affect Risk of Depression, Inflammation 3
(Date:11/25/2009)...,Nov.25/PRNewswire/--SwissrayInternational,Inc.ale...systems,announcedtodaythatitsoperationshavebeenacq...dsgrowingSwissray,smedicalimagingbrand.Theacquisit...ascontractsandinventory.After25yearsofsuccessandgr...ologicaladvancementswithstableandsteadygrowth. ,...
(Date:11/25/2009)...ewswire/--Reportlinker.comannouncesthatanewmarketr...ranasalDrugDelivery-USMarketTrends&Analysis h...g-Delivery---US-Market-Trends--Analysis.html ,...xpansionoftherapeuticapplicationsfromthedeliveryof...stemictherapeuticdrugs.Thefutureofthetechnologyhin...
(Date:11/24/2009)...PRNewswire/-- ,, WHAT:RomHoubens,aBelgianmantho...ent,wasactuallyfullyconsciousandawakeduringthattim...ynaVoxEyeMaxwasfeaturedinthesegmenttoillustratehow...lockcommunication. ,, WHEN:GoodMorningAmerica--...oxtech.com ,, WHO:RomHoubenswasanengineerin...
Breaking Medicine Technology:Swissray International Announces New Ownership 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5DynaVox EyeMax Featured in Good Morning America Segment About Man Thought To Be in Coma for 23 Years 2Herbruck Alder to Convene Summit 3A Coming Together to Explain Healthcare Legislation 54254 1Really Think Different 54252 1Really Think Different 54252 2Temple University Health System to Benefit from Verizon Wireless Network Enhancements 54250 1Temple University Health System to Benefit from Verizon Wireless Network Enhancements 54250 2Temple University Health System to Benefit from Verizon Wireless Network Enhancements 54250 3
...rch 6 The American Medical Association (AMA) Foun...09 Seed Grant Research Program. Established in 20...students, physician residents and fellows to condu...jects. This year,s award winners are conducting r... , Cardiovascular/pulmonary diseases , ...
...rmatology Division of Valeant Pharmaceuticals Intr...o Increase Patient Satisfaction and Use , , SAN F...xpanded dermatology division of Valeant Pharmaceut...ay the commercial launch of Acanya(TM) Gel (clinda...dicated for the once-daily treatment of acne vulga...
Other Medicine Technology:AMA Foundation Announces Seed Grant Research Recipients 2AMA Foundation Announces Seed Grant Research Recipients 3Acanya(TM) Gel, a New Treatment for Moderate to Severe Acne, Launched by Coria Laboratories 2Acanya(TM) Gel, a New Treatment for Moderate to Severe Acne, Launched by Coria Laboratories 3Acanya(TM) Gel, a New Treatment for Moderate to Severe Acne, Launched by Coria Laboratories 4Acanya(TM) Gel, a New Treatment for Moderate to Severe Acne, Launched by Coria Laboratories 5
Operating Otoscope
2.5V PocketScope Otoscope/Throat Illuminator
3.5V MacroViewOtoscope
3.5V MacroViewOtoscope/Throat Illuminator
Medicine Products: